» Articles » PMID: 24762113

Short Stature, Accelerated Bone Maturation, and Early Growth Cessation Due to Heterozygous Aggrecan Mutations

Overview
Specialty Endocrinology
Date 2014 Apr 26
PMID 24762113
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Many children with idiopathic short stature have a delayed bone age. Idiopathic short stature with advanced bone age is far less common.

Objective: The aim was to identify underlying genetic causes of short stature with advanced bone age.

Setting And Design: We used whole-exome sequencing to study three families with autosomal-dominant short stature, advanced bone age, and premature growth cessation.

Results: Affected individuals presented with short stature [adult heights -2.3 to -4.2 standard deviation scores (SDS)] with histories of early growth cessation or childhood short stature (height SDS -1.9 to -3.5 SDS), advancement of bone age, and normal endocrine evaluations. Whole-exome sequencing identified novel heterozygous variants in ACAN, which encodes aggrecan, a proteoglycan in the extracellular matrix of growth plate and other cartilaginous tissues. The variants were present in all affected, but in no unaffected, family members. In Family 1, a novel frameshift mutation in exon 3 (c.272delA) was identified, which is predicted to cause early truncation of the aggrecan protein. In Family 2, a base-pair substitution was found in a highly conserved location within a splice donor site (c.2026+1G>A), which is also likely to alter the amino acid sequence of a large portion of the protein. In Family 3, a missense variant (c.7064T>C) in exon 14 affects a highly conserved residue (L2355P) and is strongly predicted to perturb protein function.

Conclusions: Our study demonstrates that heterozygous mutations in ACAN can cause a mild skeletal dysplasia, which presents clinically as short stature with advanced bone age. The accelerating effect on skeletal maturation has not previously been noted in the few prior reports of human ACAN mutations. Our findings thus expand the spectrum of ACAN defects and provide a new molecular genetic etiology for the unusual child who presents with short stature and accelerated skeletal maturation.

Citing Articles

Treatment of Short Stature in Aggrecan-deficient Patients With Recombinant Human GH: 3-year Response.

Muthuvel G, Dauber A, Alexandrou E, Tyzinski L, Hwa V, Backeljauw P J Endocr Soc. 2024; 8(12):bvae177.

PMID: 39502477 PMC: 11535719. DOI: 10.1210/jendso/bvae177.


Genotype and phenotype in patients with ACAN gene variants: Three cases and literature review.

Tang W, Wu K, Zhou Q, Tang Y, Fu J, Dong G Mol Genet Genomic Med. 2024; 12(4):e2439.

PMID: 38613222 PMC: 11015147. DOI: 10.1002/mgg3.2439.


Proteoglycan Dysfunction: A Common Link Between Intervertebral Disc Degeneration and Skeletal Dysplasia.

Sao K, Risbud M Neurospine. 2024; 21(1):162-178.

PMID: 38569642 PMC: 10992626. DOI: 10.14245/ns.2347342.671.


Genetic evaluation using next-generation sequencing of children with short stature: a single tertiary-center experience.

Kim S, Joo E, Park J, Seol C, Lee J Ann Pediatr Endocrinol Metab. 2024; 29(1):38-45.

PMID: 38461804 PMC: 10925784. DOI: 10.6065/apem.2346036.018.


Role of genetic investigation in the diagnosis of short stature in a cohort of Italian children.

Cavarzere P, Pietrobelli A, Gandini A, Munari S, Baffico A, Maffei M J Endocrinol Invest. 2023; 47(5):1237-1250.

PMID: 38087044 DOI: 10.1007/s40618-023-02243-9.


References
1.
Cohen P, Rogol A, Deal C, Saenger P, Reiter E, Ross J . Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology.... J Clin Endocrinol Metab. 2008; 93(11):4210-7. DOI: 10.1210/jc.2008-0509. View

2.
Wang S, Carmichael H, Andrew S, Miller T, Moon J, Derr M . Large-scale pooled next-generation sequencing of 1077 genes to identify genetic causes of short stature. J Clin Endocrinol Metab. 2013; 98(8):E1428-37. PMC: 3733853. DOI: 10.1210/jc.2013-1534. View

3.
Tompson S, Merriman B, Funari V, Fresquet M, Lachman R, Rimoin D . A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan. Am J Hum Genet. 2008; 84(1):72-9. PMC: 2668039. DOI: 10.1016/j.ajhg.2008.12.001. View

4.
Hirai T, Chagin A, Kobayashi T, Mackem S, Kronenberg H . Parathyroid hormone/parathyroid hormone-related protein receptor signaling is required for maintenance of the growth plate in postnatal life. Proc Natl Acad Sci U S A. 2010; 108(1):191-6. PMC: 3017151. DOI: 10.1073/pnas.1005011108. View

5.
Olney R, Bukulmez H, Bartels C, Prickett T, Espiner E, Potter L . Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. J Clin Endocrinol Metab. 2005; 91(4):1229-32. DOI: 10.1210/jc.2005-1949. View